Serum sodium predicts mortality 10 times higher in PAH patients

Patients with pulmonary arterial hypertension (PAH)—chronically high blood pressure in the blood vessels of the lungs—whose serum sodium levels are low (called hyponatremia, or HN) have a very poor chance of survival and a high rate of right-heart failure (RHF), according to new research from the University of Pennsylvania.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news132573600.html">Serum sodium predicts mortality 10 times higher in PAH patients</a></p> <p>Patients with pulmonary arterial hypertension (PAH)—chronically high blood pressure in the blood vessels of the lungs—whose serum sodium levels are low (called hyponatremia, or HN) have a very poor chance of survival and a high rate of right-heart failure (RHF), according to new research from the University of Pennsylvania.</p>